Although laser treatments have revolutionised medical aesthetics, post-inflammatory hyperpigmentation (PIH) — one of the most frequently encountered complications — continues to be a concern for both patients and clinicians. This darkening is usually temporary, but if not managed correctly it can persist for months.
What Is Post-Laser Hyperpigmentation?
The controlled thermal injury delivered to the skin during a laser procedure triggers an inflammatory response. In some patients this inflammation over-stimulates melanocytes, causing a darker colour change in the treated area compared to the surrounding skin. This condition is called post-inflammatory hyperpigmentation.
Hyperpigmentation typically appears 1–4 weeks after the procedure and can range in shade from light brown to dark brown.
Risk Factors
Skin Type: This is the most important risk factor. Fitzpatrick skin types III–VI (olive and darker skin tones) are significantly more prone to hyperpigmentation. A large proportion of patients with medium to darker complexions fall into this risk group.
Laser Parameters Used: High energy levels, short wavelengths and aggressive treatment protocols increase the risk. In particular, the Alexandrite laser significantly raises the risk of hyperpigmentation in darker skin types.
Sun Exposure: Skin exposed to the sun before or after treatment is far more inclined to develop hyperpigmentation. Laser treatment on tanned skin is strongly inadvisable.
Hormonal Factors: Pregnancy, oral contraceptive use, and a history of melasma are among the hormonal factors that increase risk.
Prevention Strategies
Prevention is at least as important as treatment — arguably more so.
Pre-Treatment Preparation:
- Sun protection should be started at least 4 weeks before the procedure.
- Topical retinoids and vitamin C serums can be used to prepare the skin.
- In high-risk patients, topical hydroquinone or alternative brightening agents may be commenced 2–4 weeks before the procedure.
- The procedure should be postponed if the skin is tanned.
During Treatment:
- The appropriate laser type and wavelength must be selected for the skin type.
- Nd:YAG laser should be preferred for darker skin tones.
- Energy levels should be increased gradually; aggressive parameters must be avoided.
- Adequate cooling must be applied.
- A test shot should be performed to assess the skin's reaction.
Post-Treatment Care:
- A broad-spectrum sunscreen of SPF 50 or higher must be applied without fail.
- Sunscreen should be reapplied every 2 hours.
- Direct sun exposure must be avoided for at least 2 weeks after treatment.
- Products that may irritate the skin (AHAs, retinoids) should be avoided for several days.
Treatment Options If Hyperpigmentation Develops
Topical Treatments:
- Hydroquinone (2–4%) is the most effective depigmenting agent.
- Alternative brightening agents such as azelaic acid, kojic acid, and arbutin.
- Topical retinoids support pigment elimination by accelerating cell turnover.
- Serums containing vitamin C and niacinamide.
Clinical Procedures:
- Chemical peels (glycolic acid, TCA peeling) may be effective for superficial pigmentation.
- Removal of pigmented cells through microdermabrasion.
- Q-switched lasers may be considered in resistant cases, though caution is advised.
- Tranexamic acid mesotherapy is a prominent approach in current 2026 practice.
Recovery Timeline
Mild hyperpigmentation typically resolves on its own within 3–6 months. Topical treatment can shorten this period. In cases of deep dermal pigmentation, recovery may take 6–12 months.
Conclusion
Post-laser hyperpigmentation is a complication that can be largely prevented with the right precautions and, when it does occur, can be treated successfully. At Virtuana Clinic, we perform a detailed assessment of each patient's skin type and risk factors, establish personalised laser parameters, and offer comprehensive pre- and post-procedure care protocols to minimise this risk. Please contact us for pricing and to book a consultation.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.